Image source : theweek.co.uk
Credits Getty Images Alt Text Magic Mushrooms Active ingredient psilocybin is found to have no harmful effects in its first clinical trial One-Minute Read Gabriel Power Thursday, December 12, 2019 - 2:47pm The active ingredient in magic mushrooms has passed the first of the clinical trials designed to see if it can one day be used to treat depression. See related F1 ace Lewis Hamilton and MotoGP star Valentino Rossi swap machines - video, pictures and social media posts In the largest-ever study so far on the chemical, called psilocybin, scientists at King’s College London (KCL) found that in reasonable doses, it was “safe and well tolerated when given to healthy volunteers”. Previous smaller studies have suggested that psilocybin “helps to alleviate depressive symptoms”, says theFinancial Times , “but these were not the larger placebo-controlled trials needed to convince medical opinion – and regulators – that it is a safe and effective treatment”, the paper adds. Psilocybin is
The Room Where It Happened
: A White House Memoir Hardcover – 23 Jun. 2020 by John Bolton (Author).
As President Trump’s National Security Advisor, John Bolton spent many of his 453 days in the room where it happened, and the facts speak for themselves.
The result is a White House memoir that is the most comprehensive and substantial account of the Trump Administration, and one of the few to date by a top-level official...
Buy now : £19.99 , FREE Delivery
(As an Amazon Associate I earn from qualifying purchases.)